Diameter of ovarian follicles, estradiol, and progesterone concentrations, and pregnancy rates in cattle treated with progestins and PGF by Smith, M.W & Stevenson, Jeffrey S.
DIAMETER OF OVARIAN FOLLICLES, ESTRADIOL AND
PROGESTERONE CONCENTRATIONS, AND PREGNANCY RATES
IN CATTLE TREATED WITH PROGESTINS AND PGF2α
M. W. Smith and J. S. Stevenson
Summary
Holstein cows and virgin heifers were
treated with progestins and PGF  before first2α
service to determine their influence on
reproductive traits.  Control cows were given
two injections of PGF  14 days apart and2α
inseminated at estrus after the second injection.
Two groups received a norgestomet ear implant
(N1) or a progesterone-releasing intravaginal
device (PRID; P1) 8 days after one injection of
PGF , followed the next day by PGF  to2α 2α
regress the corpus luteum, and the progestin
source was removed 7 days later.  The last two
treatments were similar except the second
injection of PGF  was given 14 days after the2α
first and norgestomet (N6) or PRID (P6)
sources were removed 1 day later.  Insemina-
tions were performed at estrus in the latter four
treatments.  Pregnancy rates and serum pro-
gesterone were higher and serum estradiol and
follicular diameters were lower in controls, P6,
and N6 treatments, where the corpus luteum
was functional during progestin treatments,
than in those treatments where the corpus lute-
um was absent (P1 and N1).  Follicle turnover
occurred more consistently in control, P6, and
N6 treatments, whereas when follicular diame-
ter and serum estradiol were greater (N1 treat-
ment), turnover did not occur as often and
pregnancy rates at first service were reduced
markedly.  Treatments with progestins must
control follicular growth, or fertility will be
reduced.
(Key Words:  PGF , Progestins, Follicles,2α
Fertility.)
Introduction
During the past 8 years, much has been
learned about the dynamics and control of
follicular growth in cattle because of our ability
to visualize and monitor the development of
individual follicles by transrectal ultrasonogra-
phy.  It is now recognized that either two, three,
or four waves of follicles develop during the
course of the estrous cycle.  These waves
develop at various stages of the cycle, with the
first wave always beginning shortly after estrus.
Follicles (2 to 4 mm in diameter) are recruited
by identifiable increases in follicle-stimulating
hormone in blood serum.  These follicles begin
to increase in diameter until one grows more
quickly and dominates or suppresses the
growth of the remaining emerging follicles.
Longer estrous cycles (>21 days) are associated
with three or four waves of follicular growth.
The first large follicle, which dominates the
remaining follicles in both ovaries, reaches its
maximal diameter around day 6 to 8 of the
cycle and is capable of ovulating, if the corpus
luteum is regressed by administering PGF2α
(Lutalyse® or Estrumate®).  If a dominant
follicle is exposed to various sources of proges-
tin before and after natural or induced regres-
sion of the corpus luteum, the follicle continues
to increase in diameter and, when it ovulates,
subsequent fertility seems to be impaired.   Our
study was designed to determine the effect of
two sources of progestin on changes in ovarian
follicular growth, concentrations of proges-
terone and estradiol, and fertility in virgin
heifers and lactating Holstein cattle exposed to
five different treatments designed to increase or
decrease fertility.
Procedures
Five treatments were employed to test our
hypothesis that holding a follicle after regres-
sion of the corpus luteum would reduce preg-
nancy rates in association with increased con-
centrations of estradiol and larger-diameter
follicles. Treatments were applied to virgin
heifers (minimum body weight of 800 lb and
13 months of age) and to lactating cows (mini-
mum of 50 days in milk) before first service.
All cattle received 25 mg of  (Lutalyse®)
on day O of the experiment, and controls were
given a second injection of  14 days later.
Two groups were given norgestomet (6-mg ear
implants) for 7 days, beginning on day 8, with
 being injected either 1 (Nl) or 6 days
(N6) after implant insertion. The remaining
two treatments consisted of two groups receiv-
ing a progesterone-releasing intravaginal de-
vice (PRID) containing 1.5 mg of progesterone
for 7 days, beginning on day 8, with 
being given either 1 (Pl ) or 6 days (P6) after
PRID insertion.
Blood samples were collected on days O, 1,
and 8 to 16 of the experiment in all cattle, and
follicles in both ovaries were monitored daily
by ultrasonography from day 8 of the experi-
ment until ovulation was detected. All cattle
were inseminated when detected in estrus
following the second injection of  or
after removal of the norgestomet ear implants
or PRID. Pregnancy diagnoses were made by
transrectal ultrasonography at day 28 and were
confirmed later by palpation of the uterus per
rectum between days 40 and 54.
Results and Discussion
Resulting pregnancy rates are summarized
in Table 1. Pregnancy rates at ultrasound
determination or by palpation were greater (P
< .05) in the control, N6, and P6 treatments
than in the N1 treatment. Fertility in the P1
treatment was intermediate between that in N1
and the other three treatments. Embryonic
survival rates ranged from 81 to 93%, with 16
embryos (7.6910) failing to survive between day
28 and days 40 to 54 of pregnancy. This late
embryonic loss probably was associated with
failure of the placenta to attach to the uterine
wall.
Concentrations of progesterone for the five
treatments are illustrated in Figure 1.
Progesterone between days 8 and 16 was
greater (P < .01) in control, N6, and P6 treat-
ments because of the continued presence of a
functional corpus luteum compared to
concentrations of progesterone in the N 1 treat-
ment in which the corpus luteum was regressed
by administering  on day 9. Concentra-
tions of progesterone were intermediate in the
P1 treatment. The PRID in the P1 treatment
maintained low (~2 ng/mL) concentrations of
progesterone, whereas the progestin activity of
the N1 or N6 treatments was not assessed and
is not reflected by the concentrations of proges-
terone shown in Figure 1.
Table 2 illustrates concentrations of estra-
diol and maximal diameter of the dominant
follicle on day 14 of the experiment (time of
 in the controls, N6, and P6 and 1 day
before removal of the progestin sources).
Diameter of the follicles was greater (P < .05)
in the N 1 and P1 treatments (corpus luteum
regressed 5 days earlier) than in the control,
N6, or P6 treatments. These differences in
diameters among treatments are reflected
mostly by concentrations of estradiol in blood
serum. The N1 treatment had greater (P < .05)
concentrations of estradiol than any of the other
treatments, which was associated with its sig-
nificantly lower fertility (Table 1).
In the absence of adequate concentrations
of progesterone or a functional corpus luteum,
the dominant follicle fails to turn over and
normal patterns of follicular growth (waves)
are not maintained during the estrous cycle.
Our study demonstrates that in the absence of
the corpus luteum (N1 and P1 treatments) or
adequate concentrations of progesterone (N1),
follicles continue to grow to larger diameters
and secrete more estradiol.  These characteris-
tics of follicular development were related to
reduced pregnancy rates (Table 1).  High con-
centrations of estradiol and(or) increased reten-
tion time of the dominant follicle had adverse
effects on the subsequent pregnancy rates.  The
lower fertility may be associated with aging of
the follicle or the egg cell found within it.
Either aging of the egg cell that eventually ovu-
lated and(or) the effects of high concentrations
of estradiol adversely altered factors related to
normal fertility.  These negative effects might
include alterations in the oviductal and uterine
environment as they prepare to nourish the
fertilized egg and developing conceptus.  Other
recent studies have suggested that improved
fertility, or prevention of lowered fertility in
some cases, is achieved by manipulating the
presence of the dominant follicle while estrus
is synchronized.  Treatments with progestins
and PGF  must synchronize follicular growth,2α
or reduced fertility will occur.
Table 1. Pregnancy Rates and Embryo Survival in Cattle Treated with Progestins and
PGF  at First Services2α
Pregnancy rates
Treatment No. of cows Ultrasound1 Palpation2 Embryo survival3
---------------------- % ----------------------
Control 43 66x 53  x 81
P6 41 58x 56x 93
N6 41 58x 51x 89
P1 41 48xy 41xy 83
N1 45 26z 27y 91
Day 28 after insemination.1
Between days 40 and 54 after insemination.2
Survival of viable embryos between day 28 and days 40 to 54 after insemination.3
Means within a column without a common superscript letter differ (P < .05).x,y,z
Table 2. Concentrations of Estradiol and Diameter of Ovulatory Follicle
Treatment No. of cows Estradiol1 Diameter of follicle1
---- pg/mL ---- ---- mm ----
Control 12  7.3 ± 0.9x 16.4x
P6  9  7.7 ± 1.0x 16.4x
N6  8  7.6 ± 1.1x 15.8x
P1  9  8.4 ± 1.0x 18.4y
N1  9 11.5 ± 1.0y 18.2y
Determined on day 14 of the experiment when the second injection of PGF  was administered1 2α
to the control, P6, and N6 treatments.
Means within a column without a common superscript letter differ (P < .05).x,y
